Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Naylor

Showing results (61-70 of 688) with videos related to

Pageof 69
Sort By:
British Journal of Pharmacology|July 1, 1979
Changes in dopamine receptor status after denervation or chronic receptor stimulation [proceedings]B Costall, R J Naylor
Current Drug Targets. CNS and Neurological Disorders|February 18, 2004
5-HT3 receptorsBrenda Costall, Robert J Naylor
Scandinavian Journal of Gastroenterology|August 1, 1990
5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disordersB Costall, R J Naylor
The Journal of Pharmacy and Pharmacology|July 1, 1976
Apomorphine as an antagonist of the dopamine response from the nucleus accumbensB Costall, R J Naylor
The Journal of Pharmacy and Pharmacology|April 1, 1975
Cholinergic modification of abnormal involuntary movements induced in the guinea-pig by intrastriatal dopamineB Costall, R J Naylor
Neuropharmacology|March 1, 1976
Mechanisms of dyskinesia induction by 1-(3,4-dihydroxyphenyl) piperazine in the ratB Costall, R J Naylor
European Journal of Pharmacology|April 1, 1976
Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesiasB Costall, R J Naylor
The British Journal of Cancer. Supplement|December 1, 1992
Neuropharmacology of emesis in relation to clinical responseB Costall, R J Naylor
Journal of Molecular Evolution|October 12, 2000
Measuring shifts in function and evolutionary opportunity using variability profiles: a case study of the globinsG J Naylor, M Gerstein
Psychopharmacologia|July 23, 1975
Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan)B Costall, R J Naylor
Pageof 69

Showing results (61-70 of 688) with videos related to

Sort By:
Pageof 69
British Journal of Pharmacology|July 1, 1979
Changes in dopamine receptor status after denervation or chronic receptor stimulation [proceedings]B Costall, R J Naylor
Current Drug Targets. CNS and Neurological Disorders|February 18, 2004
5-HT3 receptorsBrenda Costall, Robert J Naylor
Scandinavian Journal of Gastroenterology|August 1, 1990
5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disordersB Costall, R J Naylor
The Journal of Pharmacy and Pharmacology|July 1, 1976
Apomorphine as an antagonist of the dopamine response from the nucleus accumbensB Costall, R J Naylor
The Journal of Pharmacy and Pharmacology|April 1, 1975
Cholinergic modification of abnormal involuntary movements induced in the guinea-pig by intrastriatal dopamineB Costall, R J Naylor
Neuropharmacology|March 1, 1976
Mechanisms of dyskinesia induction by 1-(3,4-dihydroxyphenyl) piperazine in the ratB Costall, R J Naylor
European Journal of Pharmacology|April 1, 1976
Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesiasB Costall, R J Naylor
The British Journal of Cancer. Supplement|December 1, 1992
Neuropharmacology of emesis in relation to clinical responseB Costall, R J Naylor
Journal of Molecular Evolution|October 12, 2000
Measuring shifts in function and evolutionary opportunity using variability profiles: a case study of the globinsG J Naylor, M Gerstein
Psychopharmacologia|July 23, 1975
Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan)B Costall, R J Naylor
Pageof 69